Drug Panel 9, Urine - Screen with Reflex to Confirmation/Quantitation
0092186
Ordering Recommendation
 
Mnemonic
CDASU 9
Methodology
Qualitative Enzyme Multiplied Immunoassay Technique/ Quantitative Gas Chromatography-Mass Spectrometry/Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Random urine.  
Specimen Preparation
Transfer 8 mL urine with no additives or preservatives to ARUP Standard Transport Tubes. (Min: 4 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Remarks
  
Stability
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years  
Reference Interval
Effective August 20, 2012
 
Drugs Covered and Cutoff Concentrations
Drugs/Drug Classes Screen
Marijuana 20 ng/mL
Cocaine 150 ng/mL
Opiates 300 ng/mL
Oxycodone 100 ng/mL
Phencyclidine 25 ng/mL
Amphetamines 300 ng/mL
MDMA (Ecstasy) 500 ng/mL
Barbiturates 200 ng/mL
Benzodiazepines 200 ng/mL
Methadone 150 ng/mL
Propoxyphene 300 ng/mL
Interpretive Data
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific technology (GC/MS and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

Oxycodone results are reported with the opiates results. MDMA results are reported with the amphetamines results. The following opioids are not detected in this test: fentanyl, buprenorphine, meperidine, tramadol, and tapentadol. A comprehensive panel that includes these opioids is available or individual opioid testing can be ordered. Refer to aruplab.com for test information.

For medical purposes only; not valid for forensic use.  
Note
If the specimen screens positive, then Confirmation/Quantitation by GC/MS and/or LC-MS/MS will be added to confirm result. Additional charges apply.

To order testing for individual opioids, refer to Fentanyl and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 0092570), Buprenorphine and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2002749), Meperidine and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 2002760), Tramadol and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2002736). For the comprehensive panel, refer to Pain Management Drug Panel by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine (ARUP test code 2007479).
CPT Code(s)
80101 x9 (HCPCS:G0431) if positive, add appropriate CPT code(s): 82542; 82520; 83925; 83992; 82145; 82205; 80154; 83840; 83925
Components
Component Test Code*Component Chart Name
0090386Creatinine, Urine
0090399CDASU 9 Comments
0092191Amphetamines, Urine
0092192Cocaine, Urine
0092193Opiates, Urine
0092194Phencyclidine, Urine
0092195Marijuana, Urine
0092196Barbiturates, Urine
0092197Benzodiazepines, Urine
0092198Propoxyphene, Urine
0092199Methadone, Urine
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Amphetamines, Urine
  • Barbiturates, Urine
  • Benzodiazepines, Urine
  • CDASU 9 Comments
  • Cocaine, Urine
  • Creatinine, Urine
  • Marijuana, Urine
  • Methadone, Urine
  • Opiates, Urine
  • Pain Management
  • Phencyclidine, Urine
  • Propoxyphene, Urine